Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Hypertension was the most common (37, 31.4%) comorbid condition followed by kidney disease (23, 19.5%) (Fig. 1).The Clinical characteristics and medication use of hospitalized heart failure patients at MRRH, Southwestern Uganda from November 2021 to January 2022VariablesCategoriesN (%)Duration of the HFNew56 (47.5)Known59 (52.5)Previous hospital admission78 (66.1)Length of hospital stay (days)Median (IQR): 8 (6 to 10)≤527 (22.9)6 to 1059 (50)≥1132 (27.1)Comorbidity93 (78.8)Number of comorbidities (N = 93)One (1)56 (60.2)Two (2) and above37 (39.8)Counseling on medication use107 (90.7)OTC use within the past 4 weeks42 (35.6)Herbal use within the past 4 weeks52 (44.1)Poly-pharmacy75 (63.5)Significant drug-drug interaction79 (66.9)Treatment affordability18 (15.3)*Others: Alcoholic liver disease, Hypothyroidism, Thyrotoxicosis, DVT Pharyngitis, ILD Cholecystitis, PUD Cellulitis, Vitamin D deficiencyCommon comorbid conditions among hospitalized heart failure patients at MRRH, Southwestern Uganda from November 2021 to January 2022
Source: Clinical and medication use characteristics. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Observational study.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
A prospective observational study was conducted among hospitalized HF patients from November 2021 to January 2022.
Source: Abstract.
An average of 30 Heart failure patients per month were admitted to the medical inpatient ward, whereas an average of 7 HF patients were admitted to the pediatric ward.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Prevalence and factors associated with adverse drug reactions among heart failure patients hospitalized at Mbarara Regional Referral Hospital, Uganda
Observational study · BMC Cardiovascular Disorders · 2022
Original publication title
Prevalence and factors associated with adverse drug reactions among heart failure patients hospitalized at Mbarara Regional Referral Hospital, Uganda
© The Author(s) 2022
Original publication · Publisher record · CC BY 4.0 · CC0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Adverse drug reaction (ADR) of medications remains an obstacle to achieving optimal disease outcomes. This study aimed to assess the prevalence and associated factors of ADR among Heart failure (HF) patients hospitalized at Mbarara Regional and Referral Hospital.
Source: BackgroundAbstract: What methods does the paper describe?
A prospective observational study was conducted among hospitalized HF patients from November 2021 to January 2022. Univariate and multivariate logistic regression was employed to determine factors associated with the ADR.
Source: MethodAbstract: Result
Overall, 118 HF patients were included in the study with a median age of 43 years. A total of 164 ADRs were identified during the follow-up period of 1011 days. The incidence of new ADRs was 106 ADRs/1000 person-days. The prevalence of ADR was 59.3%. Of the 164 ADRs, 118(71.9%) were probable. The gastrointestinal system was the most frequently (27.5%) affected system. Over half (86, 52.4%) of the ADRs were mild and 96(58.5%) were preventable. Age group 19 to 59(AOR 0.15[0.03 to 0.35] at 95%CI, p = 0.013), herbal use (AOR 3.07[1.01 to 9.32] at 95%CI, p = 0.048), poly-pharmacy (AOR 8.7[2.4 to 15.77] at 95%CI, p < 0.001) and drug-drug interaction (AOR 6.06[2.79 to 12.5] at 95%CI, p = 0.004) were significantly associated with ADRs among HF patients.
Source: ResultAbstract: Conclusion
More than half of the hospitalized HF patients experienced at least one ADR during their hospital stay. The use of herbal medicines, poly-pharmacy, and drug-drug interaction were associated with a high risk of ARDs whereas the age group 19 to 59 years was less likely to experience ADRs.
Source: ConclusionAuthors’ abstract
Background
Adverse drug reaction (ADR) of medications remains an obstacle to achieving optimal disease outcomes. This study aimed to assess the prevalence and associated factors of ADR among Heart failure (HF) patients hospitalized at Mbarara Regional and Referral Hospital.
Method
A prospective observational study was conducted among hospitalized HF patients from November 2021 to January 2022. Univariate and multivariate logistic regression was employed to determine factors associated with the ADR.
Result
Overall, 118 HF patients were included in the study with a median age of 43 years. A total of 164 ADRs were identified during the follow-up period of 1011 days. The incidence of new ADRs was 106 ADRs/1000 person-days. The prevalence of ADR was 59.3%. Of the 164 ADRs, 118(71.9%) were probable. The gastrointestinal system was the most frequently (27.5%) affected system. Over half (86, 52.4%) of the ADRs were mild and 96(58.5%) were preventable. Age group 19 to 59(AOR 0.15[0.03 to 0.35] at 95%CI, p = 0.013), herbal use (AOR 3.07[1.01 to 9.32] at 95%CI, p = 0.048), poly-pharmacy (AOR 8.7[2.4 to 15.77] at 95%CI, p < 0.001) and drug-drug interaction (AOR 6.06[2.79 to 12.5] at 95%CI, p = 0.004) were significantly associated with ADRs among HF patients.
Conclusion
More than half of the hospitalized HF patients experienced at least one ADR during their hospital stay. The use of herbal medicines, poly-pharmacy, and drug-drug interaction were associated with a high risk of ARDs whereas the age group 19 to 59 years was less likely to experience ADRs.
Publication and source details
Original title: Prevalence and factors associated with adverse drug reactions among heart failure patients hospitalized at Mbarara Regional Referral Hospital, Uganda
Efrata Ashuro Shegena; Konjit Abebe Nigussie; Robert Tamukong; Boniface Amanee Elias Lumori; Tadele Mekuriya Yadesa
BMC Cardiovascular Disorders · 2022
© The Author(s) 2022https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T21:49:16.307989+00:00
DOI: 10.1186/s12872-022-02937-7 · PMC9650824